These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 23992479

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The sputum microbiome is distinct between COPD and health, independent of smoking history.
    Haldar K, George L, Wang Z, Mistry V, Ramsheh MY, Free RC, John C, Reeve NF, Miller BE, Tal-Singer R, Webb AJ, Brookes AJ, Tobin MD, Singh D, Donaldson GC, Wedzicha JA, Brown JR, Barer MR, Brightling CE.
    Respir Res; 2020 Jul 14; 21(1):183. PubMed ID: 32664956
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antagonistic Pleiotropy in the Bifunctional Surface Protein FadL (OmpP1) during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease.
    Moleres J, Fernández-Calvet A, Ehrlich RL, Martí S, Pérez-Regidor L, Euba B, Rodríguez-Arce I, Balashov S, Cuevas E, Liñares J, Ardanuy C, Martín-Santamaría S, Ehrlich GD, Mell JC, Garmendia J.
    mBio; 2018 Sep 25; 9(5):. PubMed ID: 30254117
    [Abstract] [Full Text] [Related]

  • 28. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W, Shen N, Du Y, Erb-Downward JR, Sun X, Guo C, Ke Q, Huffnagle GB, Gyetko MR, He B.
    Int J Chron Obstruct Pulmon Dis; 2018 Sep 25; 13():2289-2299. PubMed ID: 30104869
    [Abstract] [Full Text] [Related]

  • 29. Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease.
    Finney LJ, Belchamber KBR, Fenwick PS, Kemp SV, Edwards MR, Mallia P, Donaldson G, Johnston SL, Donnelly LE, Wedzicha JA.
    Am J Respir Crit Care Med; 2019 Jun 15; 199(12):1496-1507. PubMed ID: 30562053
    [Abstract] [Full Text] [Related]

  • 30. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
    Garcia-Nuñez M, Millares L, Pomares X, Ferrari R, Pérez-Brocal V, Gallego M, Espasa M, Moya A, Monsó E.
    J Clin Microbiol; 2014 Dec 15; 52(12):4217-23. PubMed ID: 25253795
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z, Singh R, Miller BE, Tal-Singer R, Van Horn S, Tomsho L, Mackay A, Allinson JP, Webb AJ, Brookes AJ, George LM, Barker B, Kolsum U, Donnelly LE, Belchamber K, Barnes PJ, Singh D, Brightling CE, Donaldson GC, Wedzicha JA, Brown JR, COPDMAP.
    Thorax; 2018 Apr 15; 73(4):331-338. PubMed ID: 29269441
    [Abstract] [Full Text] [Related]

  • 34. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.
    Singh M, Lee SH, Porter P, Xu C, Ohno A, Atmar RL, Greenberg SB, Bandi V, Gern J, Amineva S, Aminev A, Skern T, Smithwick P, Perusich S, Barrow N, Roberts L, Corry DB, Kheradmand F.
    J Allergy Clin Immunol; 2010 Jun 15; 125(6):1369-1378.e2. PubMed ID: 20430426
    [Abstract] [Full Text] [Related]

  • 35. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
    Quint JK, Donaldson GC, Goldring JJ, Baghai-Ravary R, Hurst JR, Wedzicha JA.
    Chest; 2010 Apr 15; 137(4):812-22. PubMed ID: 19837822
    [Abstract] [Full Text] [Related]

  • 36. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
    Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, Murphy E, Johnston SL, Schwartz DA, Wells AU, Cookson WO, Maher TM, Moffatt MF.
    Am J Respir Crit Care Med; 2014 Oct 15; 190(8):906-13. PubMed ID: 25184687
    [Abstract] [Full Text] [Related]

  • 37. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.
    Barker BL, Haldar K, Patel H, Pavord ID, Barer MR, Brightling CE, Bafadhel M.
    Chest; 2015 Jan 15; 147(1):46-55. PubMed ID: 25103335
    [Abstract] [Full Text] [Related]

  • 38. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH, Tsao KC, Hu HC, Huang CC, Kao KC, Chen NH, Yang CT, Tsai YH, Hsieh MJ.
    Int J Chron Obstruct Pulmon Dis; 2015 Jan 15; 10():767-74. PubMed ID: 25926728
    [Abstract] [Full Text] [Related]

  • 39. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
    Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, Chen V, FitzGerald JM, Nislow C, Leung JM, Man SFP, Sin DD.
    Am J Respir Crit Care Med; 2019 May 15; 199(10):1205-1213. PubMed ID: 30376356
    [Abstract] [Full Text] [Related]

  • 40. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ, Huang JTJ, Lonergan M, Keir HR, Fong CJ, Tan B, Cassidy AJ, Finch S, Mullerova H, Miller BE, Tal-Singer R, Chalmers JD.
    J Allergy Clin Immunol; 2021 Jan 15; 147(1):158-167. PubMed ID: 32353489
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.